4.7 Article

Therapy of Organophosphate Poisoning via Intranasal Administration of 2-PAM-Loaded Chitosomes

期刊

PHARMACEUTICS
卷 14, 期 12, 页码 -

出版社

MDPI
DOI: 10.3390/pharmaceutics14122846

关键词

chitosomes; arginine chitosan; acetylcholinesterase reactivation; intranasal delivery; pralidoxime chloride; organophosphorus compounds

资金

  1. Russian Science Foundation
  2. [19-73-30012]

向作者/读者索取更多资源

Chitosan-decorated liposomes were developed for the intranasal delivery of a reactivator for acetylcholinesterase in the brain as a therapy for poisoning from organophosphorus compounds. The polymer modification increased the encapsulation efficiency and stability of the liposomes. In vitro and in vivo experiments demonstrated the permeability of the chitosomes and their ability to reactivate brain AChE.
Chitosan-decorated liposomes were proposed for the first time for the intranasal delivery of acetylcholinesterase (AChE) reactivator pralidoxime chloride (2-PAM) to the brain as a therapy for organophosphorus compounds (OPs) poisoning. Firstly, the chitosome composition based on phospholipids, cholesterol, chitosans (Cs) of different molecular weights, and its arginine derivative was developed and optimized. The use of the polymer modification led to an increase in the encapsulation efficiency toward rhodamine B (RhB; similar to 85%) and 2-PAM (similar to 60%) by 20% compared to conventional liposomes. The formation of monodispersed and stable nanosized particles with a hydrodynamic diameter of up to 130 nm was shown using dynamic light scattering. The addition of the polymers recharged the liposome surface (from -15 mV to +20 mV), which demonstrates the successful deposition of Cs on the vesicles. In vitro spectrophotometric analysis showed a slow release of substrates (RhB and 2-PAM) from the nanocontainers, while the concentration and Cs type did not significantly affect the chitosome permeability. Flow cytometry and fluorescence microscopy qualitatively and quantitatively demonstrated the penetration of the developed chitosomes into normal Chang liver and M-HeLa cervical cancer cells. At the final stage, the ability of the formulated 2-PAM to reactivate brain AChE was assessed in a model of paraoxon-induced poisoning in an in vivo test. Intranasal administration of 2-PAM-containing chitosomes allows it to reach the degree of enzyme reactivation up to 35 +/- 4%.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据